Savara
Price & Volume
Stats
See moreOpen | $2.43 |
Previous Close | $2.39 |
Day Range | $2.43-$2.57 |
52W Range | $2.25-$5.60 |
Market Cap | $398.1M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $1,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$67.4M |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • 2 years ago
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance • 2 years ago
Savara Completes Enrollment of Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Yahoo Finance • 3 years ago
Savara Announces Resignation of Chief Medical Officer
Yahoo Finance • 3 years ago
Savara Reports Second Quarter 2022 Financial Results and Provides Business Update
About
CEO | Mr. Matthew Pauls J.D., M.B.A. |
CFO | Mr. David L. Lowrance CPA |
Address | 1717 Langhorne Newtown Road, Langhorne, PA, United States, 19047 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 37 |
